This is a table of type bigram and their frequencies. Use it to search & browse the list to learn more about your study carrel.
bigram | frequency |
---|---|
spike protein | 1287 |
respiratory syndrome | 1275 |
acute respiratory | 1206 |
severe acute | 1080 |
syndrome coronavirus | 898 |
novel coronavirus | 887 |
amino acid | 852 |
cord uid | 702 |
doc id | 702 |
biorxiv doi | 701 |
gene expression | 615 |
cell types | 521 |
immune response | 511 |
epithelial cells | 503 |
coronavirus disease | 475 |
sars coronavirus | 450 |
receptor binding | 440 |
binding domain | 422 |
spike glycoprotein | 414 |
performed using | 404 |
neutralizing antibodies | 396 |
viral rna | 392 |
viral replication | 374 |
host cell | 372 |
human ace | 371 |
infected cells | 363 |
converting enzyme | 353 |
type i | 346 |
room temperature | 332 |
virus infection | 331 |
immune responses | 329 |
viral infection | 324 |
amino acids | 321 |
supplementary table | 317 |
innate immune | 308 |
cell entry | 307 |
binding affinity | 300 |
extended data | 292 |
coronavirus spike | 287 |
severe covid | 287 |
viral genome | 281 |
ace receptor | 277 |
molecular dynamics | 273 |
crystal structure | 272 |
previously described | 266 |
single cell | 264 |
rna viruses | 264 |
cell lines | 262 |
ace expression | 262 |
cell type | 260 |
binding site | 255 |
influenza virus | 252 |
new coronavirus | 251 |
antiviral activity | 250 |
seq data | 245 |
nucleic acid | 244 |
sequencing data | 243 |
vero cells | 237 |
middle east | 234 |
host cells | 233 |
active site | 231 |
endothelial cells | 230 |
neutralizing antibody | 229 |
viral entry | 228 |
secondary structure | 227 |
machine learning | 222 |
cell rna | 219 |
human sars | 218 |
cleavage site | 217 |
mg kg | 216 |
cell culture | 212 |
infectious diseases | 212 |
east respiratory | 212 |
sequence alignment | 211 |
thermo fisher | 209 |
monoclonal antibodies | 209 |
structural basis | 208 |
immune system | 206 |
public health | 206 |
virus replication | 203 |
rna polymerase | 203 |
electron microscopy | 199 |
human coronavirus | 197 |
cell line | 195 |
viral proteins | 194 |
cell epitopes | 194 |
spike proteins | 192 |
mg ml | 190 |
clinical trials | 190 |
structural proteins | 189 |
epi isl | 188 |
cell receptor | 186 |
em structure | 182 |
cytokine storm | 181 |
stem cells | 181 |
previous studies | 181 |
flow cytometry | 180 |
taken together | 180 |
viral load | 179 |
orf ab | 179 |
free energy | 178 |
differentially expressed | 176 |
highly conserved | 175 |
respiratory tract | 174 |
closely related | 173 |
wild type | 171 |
respiratory disease | 166 |
clinical samples | 164 |
genome sequences | 163 |
ng ml | 163 |
human lung | 162 |
results suggest | 162 |
rna virus | 161 |
membrane fusion | 160 |
bat cov | 159 |
cell responses | 159 |
sars cov | 158 |
cell surface | 158 |
immune cells | 156 |
protease inhibitor | 156 |
mm nacl | 156 |
human coronaviruses | 156 |
large number | 155 |
rna sequencing | 155 |
reverse transcription | 155 |
lung injury | 153 |
total number | 152 |
binding sites | 152 |
cov spike | 152 |
present study | 150 |
viral infections | 149 |
disease severity | 149 |
negative control | 148 |
previously reported | 148 |
protein structure | 148 |
protein interaction | 147 |
reference genome | 147 |
data analysis | 147 |
respiratory distress | 146 |
coronavirus infection | 145 |
ace binding | 144 |
two different | 144 |
statistically significant | 144 |
positive control | 144 |
ebola virus | 143 |
md simulations | 143 |
phylogenetic tree | 143 |
positive selection | 142 |
peripheral blood | 142 |
well plates | 141 |
whole genome | 141 |
hydrogen bonds | 140 |
human respiratory | 139 |
receptor ace | 138 |
bat origin | 138 |
time points | 137 |
least one | 137 |
mass spectrometry | 136 |
animal models | 136 |
pdb id | 135 |
vaccine development | 135 |
expressed genes | 135 |
target cells | 134 |
cell death | 134 |
kcal mol | 134 |
way anova | 133 |
authors declare | 133 |
may also | 132 |
results indicate | 131 |
protein expression | 131 |
stem cell | 131 |
deep learning | 131 |
fisher scientific | 131 |
i interferon | 130 |
zika virus | 130 |
monoclonal antibody | 130 |
multiple sequence | 129 |
main protease | 129 |
antibody responses | 128 |
world health | 128 |
differential expression | 127 |
human monoclonal | 127 |
class i | 127 |
codon usage | 126 |
human cells | 126 |
high levels | 125 |
protein interactions | 125 |
expression levels | 125 |
terminal domain | 124 |
stranded rna | 124 |
virus entry | 124 |
rna extraction | 123 |
mouse model | 123 |
enrichment analysis | 123 |
airway epithelial | 123 |
phylogenetic analysis | 123 |
rhesus macaques | 122 |
calculated using | 122 |
basal cells | 122 |
determine whether | 121 |
pneumonia outbreak | 121 |
distress syndrome | 121 |
conformational changes | 120 |
inflammatory cytokines | 120 |
inflammatory response | 120 |
probable bat | 120 |
transcription factor | 120 |
severe disease | 120 |
generated using | 120 |
significantly higher | 119 |
innate immunity | 119 |
protein sequences | 118 |
lung cells | 118 |
health organization | 118 |
data sets | 117 |
protein sequence | 117 |
significant differences | 116 |
ace protein | 116 |
prefusion conformation | 116 |
standard deviation | 115 |
systematic review | 115 |
viral genomes | 115 |
human airway | 115 |
dependent rna | 115 |
coronavirus associated | 114 |
infectious disease | 114 |
receptor recognition | 114 |
outbreak associated | 114 |
like protease | 114 |
see methods | 114 |
generation sequencing | 113 |
even though | 113 |
gene set | 113 |
mm tris | 113 |
plasma membrane | 113 |
united states | 113 |
analysis revealed | 113 |
antibody response | 112 |
force field | 111 |
nucleocapsid protein | 111 |
error bars | 110 |
days post | 110 |
web server | 109 |
entry depends | 109 |
clinical characteristics | 108 |
data set | 108 |
rna synthesis | 108 |
sequence identity | 107 |
clinically proven | 107 |
sialic acid | 107 |
cov infection | 106 |
statistical analysis | 106 |
dendritic cells | 106 |
described previously | 106 |
also observed | 105 |
final concentration | 105 |
total rna | 105 |
see table | 105 |
drug repurposing | 105 |
epithelial cell | 104 |
highly expressed | 103 |
acid residues | 103 |
endoplasmic reticulum | 103 |
proven protease | 103 |
publicly available | 102 |
positive cells | 102 |
genome sequencing | 102 |
expression data | 101 |
fold change | 101 |
patients infected | 101 |
host immune | 101 |
coronavirus sars | 100 |
data collection | 100 |
three times | 100 |
kenyon cells | 100 |
reference sequence | 100 |
protein structures | 100 |
high affinity | 100 |
genomic rna | 100 |
viral particles | 100 |
neural networks | 100 |
widely used | 99 |
small molecule | 99 |
spike receptor | 99 |
analyzed using | 99 |
nucleic acids | 99 |
data suggest | 98 |
mhc class | 98 |
fusion protein | 98 |
sequence data | 98 |
human genome | 98 |
acid sequence | 98 |
important role | 98 |
global health | 97 |
bovine serum | 97 |
growth factor | 97 |
competing interests | 97 |
synonymous mutations | 97 |
per well | 96 |
drug discovery | 96 |
immunodeficiency virus | 96 |
statistical significance | 95 |
genome sequence | 95 |
ncov spike | 95 |
recent study | 94 |
transcription factors | 94 |
made available | 93 |
hydrogen bond | 93 |
crystal structures | 93 |
time series | 93 |
type ii | 93 |
also found | 93 |
hospitalized patients | 92 |
pl pro | 91 |
copy number | 91 |
mutation rate | 91 |
open reading | 91 |
specific antibodies | 90 |
minor variants | 89 |
dynamics simulations | 89 |
cell membrane | 89 |
previous study | 89 |
quality control | 89 |
angiotensin converting | 89 |
single nucleotide | 89 |
vaccine candidate | 89 |
dna methylation | 88 |
cell cycle | 88 |
expression analysis | 88 |
first step | 87 |
cell populations | 87 |
results show | 86 |
two distinct | 86 |
risk factors | 86 |
wide range | 86 |
surface area | 86 |
three different | 86 |
viral spike | 85 |
reading frame | 85 |
dependent manner | 85 |
current study | 85 |
approved drugs | 85 |
host response | 85 |
clinical features | 84 |
hepatitis virus | 84 |
small molecules | 84 |
rna genome | 84 |
cells expressing | 83 |
binding motifs | 83 |
adipose tissue | 83 |
infectious virus | 83 |
ct values | 83 |
lung tissue | 83 |
related coronavirus | 83 |
cytopathic effect | 83 |
human immunodeficiency | 83 |
lysis buffer | 82 |
culture medium | 82 |
cell differentiation | 82 |
ms ms | 82 |
molecular weight | 82 |
cleavage sites | 82 |
immune repertoire | 82 |
infected mice | 81 |
experimental data | 81 |
furin cleavage | 81 |
accessory calyx | 81 |
vaccine design | 80 |
time pcr | 80 |
host proteins | 80 |
time rt | 80 |
alveolar macrophages | 80 |
enveloped viruses | 79 |
binding motif | 79 |
memory cd | 79 |
immune cell | 79 |
allowed us | 79 |
time point | 79 |
infected patients | 79 |
raw data | 79 |
glucose uptake | 79 |
single cells | 79 |
viral protein | 79 |
bat sars | 79 |
gene ontology | 79 |
structure prediction | 78 |
binding free | 78 |
i ifn | 78 |
positive samples | 78 |
results showed | 78 |
human cell | 78 |
mrna expression | 77 |
full length | 77 |
respiratory viruses | 77 |
respiratory syncytial | 77 |
inflammatory responses | 77 |
virus particles | 77 |
cells using | 77 |
plaque assay | 77 |
magnetic stimulation | 77 |
protease inhibitors | 77 |
acid sequences | 76 |
heavy chain | 76 |
nsp protein | 76 |
confirmed cases | 76 |
ace cells | 76 |
neural network | 76 |
immune evasion | 76 |
high throughput | 76 |
serine protease | 75 |
recent studies | 75 |
whole blood | 75 |
determined using | 75 |
cell immunity | 75 |
mm hepes | 75 |
spectrum antiviral | 75 |
copyright holder | 74 |
real time | 74 |
significant difference | 74 |
structure determination | 74 |
global pandemic | 74 |
signaling pathway | 74 |
side chain | 73 |
convalescent plasma | 73 |
data bank | 73 |
urgent need | 73 |
nervous system | 73 |
post infection | 73 |
cd cd | 72 |
viral loads | 72 |
graphpad prism | 72 |
genomic dna | 72 |
cell viability | 72 |
membrane protein | 71 |
higher levels | 71 |
commonly used | 71 |
body weight | 71 |
cell response | 71 |
dna sequences | 71 |
syncytial virus | 71 |
author funder | 71 |
functional receptor | 71 |
lung epithelial | 71 |
western blot | 71 |
orf protein | 70 |
protein data | 70 |
virus type | 70 |
antibody binding | 70 |
physical activity | 70 |
envelope protein | 70 |
sample size | 70 |
network analysis | 70 |
protein binding | 70 |
different types | 70 |
drug design | 70 |
commercially available | 70 |
see supplementary | 70 |
structural studies | 70 |
mouse hepatitis | 70 |
class ii | 70 |
also identified | 70 |
life cycle | 70 |
well plate | 70 |
viral input | 69 |
multiplex pcr | 69 |
genes involved | 69 |
drug targets | 69 |
associated genes | 69 |
tmprss expression | 69 |
specific cd | 69 |
sequence similarity | 69 |
molecular docking | 69 |
master mix | 69 |
transgenic mice | 69 |
across different | 69 |
human population | 69 |
pcr assays | 68 |
better understand | 68 |
significantly lower | 68 |
biological processes | 68 |
expression patterns | 68 |
coronavirus replication | 68 |
van der | 68 |
dorsal accessory | 68 |
dna polymerase | 68 |
cov nsp | 68 |
acute lung | 68 |
primary human | 68 |
human protein | 68 |
type diabetes | 68 |
proteolytic cleavage | 68 |
hours post | 67 |
escherichia coli | 67 |
biorxiv preprint | 67 |
previous work | 67 |
ligand binding | 66 |
cell activation | 66 |
multiple comparisons | 66 |
future studies | 66 |
flow rate | 66 |
antiviral drug | 66 |
viral envelope | 66 |
day post | 66 |
genetic information | 66 |
based approach | 66 |
obtained using | 66 |
copies ml | 66 |
may provide | 66 |
expression level | 65 |
target genes | 65 |
binding mode | 65 |
dengue virus | 65 |
pulmonary surfactant | 65 |
relatively high | 65 |
reverse transcriptase | 65 |
cell epitope | 65 |
pathway analysis | 65 |
transcranial magnetic | 65 |
er stress | 65 |
high level | 65 |
structural analysis | 65 |
adaptive immune | 65 |
inhibitory activity | 65 |
antibody titers | 65 |
reading frames | 64 |
sustentacular cells | 64 |
thermofisher scientific | 64 |
secondary structures | 64 |
supplementary material | 64 |
least two | 64 |
per sample | 64 |
library preparation | 64 |
blood samples | 64 |
bone marrow | 64 |
cytokine production | 64 |
clinical trial | 63 |
rbd protein | 63 |
binding pocket | 63 |
data processing | 63 |
type iii | 63 |
molecular mechanisms | 63 |
high expression | 63 |
significantly reduced | 63 |
ge healthcare | 63 |
related genes | 63 |
secondary antibodies | 63 |
neutralizing activity | 63 |
data indicate | 63 |
maximum likelihood | 63 |
drug development | 63 |
false positive | 62 |
also known | 62 |
strand rna | 62 |
cells per | 62 |
animal species | 62 |
marker genes | 62 |
alveolar epithelial | 62 |
measured using | 62 |
binding interface | 62 |
binding protein | 62 |
rbd ace | 62 |
genome coverage | 62 |
specific antibody | 62 |
host factors | 61 |
virus infections | 61 |
binding affinities | 61 |
much higher | 61 |
mutation rates | 61 |
human igg | 61 |
like receptor | 61 |
binding domains | 61 |
antiviral drugs | 61 |
first time | 61 |
binding proteins | 61 |
also showed | 61 |
fold higher | 60 |
next generation | 60 |
also used | 60 |
pluripotent stem | 60 |
increased expression | 60 |
independent experiments | 60 |
human transmission | 60 |
anp high | 60 |
length human | 60 |
supplemental table | 60 |
genetic diversity | 60 |
intrinsic disorder | 60 |
ic values | 60 |
hydrophobic interactions | 60 |
better understanding | 60 |
critical role | 60 |
rbd domain | 60 |
cell proliferation | 60 |
human proteins | 59 |
set enrichment | 59 |
rna secondary | 59 |
expressing cells | 59 |
human tissues | 59 |
accession number | 59 |
adj gla | 59 |
bat coronavirus | 59 |
vaccine candidates | 59 |
new england | 59 |
ex vivo | 59 |
cell population | 59 |
smooth muscle | 59 |
serial dilutions | 59 |
significantly different | 59 |
fetal bovine | 58 |
cell data | 58 |
genomic sequences | 58 |
using human | 58 |
may contribute | 58 |
igg antibodies | 58 |
may play | 58 |
reference sequences | 58 |
domain bound | 58 |
disease progression | 58 |
spike rbd | 58 |
ace complex | 58 |
protein kinase | 58 |
bp kenyon | 58 |
spinal cord | 58 |
ros production | 58 |
protein complex | 58 |
animal model | 58 |
ace interaction | 57 |
potent neutralizing | 57 |
protective immunity | 57 |
seq analysis | 57 |
inhibit sars | 57 |
isothermal amplification | 57 |
tissue culture | 57 |
fusion peptide | 57 |
ace interface | 57 |
disease map | 57 |
modern hopfield | 57 |
expression profiles | 57 |
influenza viruses | 57 |
bars represent | 57 |
secondary antibody | 57 |
data using | 57 |
differential gene | 57 |
hierarchical clustering | 57 |
drosophila melanogaster | 57 |
secondary site | 57 |
progenitor cells | 57 |
sample preparation | 57 |
likely due | 56 |
rbd binding | 56 |
attention mechanism | 56 |
rna replication | 56 |
coding sequences | 56 |
weight loss | 56 |
applied biosystems | 56 |
cohort study | 56 |
mrna levels | 56 |
human angiotensin | 56 |
high quality | 56 |
antiviral response | 56 |
crispr cas | 56 |
cell atlas | 56 |
firing rates | 56 |
data points | 56 |
soluble ace | 56 |
cancer cells | 56 |
component analysis | 56 |
large scale | 55 |
including sars | 55 |
treated cells | 55 |
two major | 55 |
results demonstrate | 55 |
chain reaction | 55 |
two independent | 55 |
comparative analysis | 55 |
olfactory bulb | 55 |
highly pathogenic | 55 |
different cell | 55 |
relative abundance | 55 |
water molecules | 55 |
per ml | 55 |
pfu ml | 54 |
coding region | 54 |
antiviral effect | 54 |
international license | 54 |
allows us | 54 |
virus genome | 54 |
much lower | 54 |
findings suggest | 54 |
genomic characterisation | 54 |
lexical stress | 54 |
airway epithelium | 54 |
genomic diversity | 54 |
patient samples | 54 |
analysis showed | 54 |
serum samples | 54 |
human pancreatic | 53 |
th cells | 53 |
previous reports | 53 |
two groups | 53 |
lung cancer | 53 |
low levels | 53 |
supplementary file | 53 |
complete genome | 53 |
cell subsets | 53 |
significant increase | 53 |
recombinant protein | 53 |
results obtained | 52 |
using two | 52 |
causative agent | 52 |
phage display | 52 |
related coronaviruses | 52 |
human host | 52 |
pcr amplification | 52 |
per cell | 52 |
fatty acid | 52 |
rna interference | 52 |
default parameters | 52 |
nucleotide sequences | 52 |
disease outbreaks | 52 |
ciliated cells | 52 |
relatively low | 52 |
also detected | 52 |
bulk rna | 52 |
one hour | 52 |
several studies | 52 |
hace mice | 51 |
common cold | 51 |
based vaccine | 51 |
trimeric spike | 51 |
sequence analysis | 51 |
signal peptide | 51 |
pcr products | 51 |
base pairs | 51 |
assessed using | 51 |
signaling pathways | 51 |
mammalian cells | 51 |
virus origins | 51 |
polymerase chain | 51 |
standard error | 51 |
ace tmprss | 51 |
fluorescent protein | 51 |
repertoire classification | 50 |
global initiative | 50 |
analysis using | 50 |
transmembrane domain | 50 |
saudi arabia | 50 |
high pmn | 50 |
key role | 50 |
ace gene | 50 |
fatality rate | 50 |
viral titers | 50 |
em structures | 50 |
md simulation | 50 |
molecular biology | 50 |
recombination events | 50 |
previously shown | 50 |
high viral | 50 |
cell growth | 50 |
ribosome profiling | 50 |
body temperature | 50 |
currently available | 50 |
protein synthesis | 50 |
fatty acids | 50 |
spike igg | 50 |
based assay | 50 |
potential therapeutic | 50 |
associated coronavirus | 50 |
previously published | 50 |
influenza infection | 50 |
paneth cell | 50 |
biological replicates | 50 |
peer review | 49 |
prostate cancer | 49 |
culture supernatants | 49 |
rna binding | 49 |
drug candidates | 49 |
ace microbody | 49 |
cells infected | 49 |
male mice | 49 |
visualized using | 49 |
viral genomic | 49 |
significantly increased | 49 |
cleavage activity | 49 |
tryptic peptides | 49 |
viral infectivity | 49 |
luciferase activity | 49 |
analysis based | 49 |
recombinant sars | 49 |
olfactory epithelium | 49 |
based methods | 49 |
buffer containing | 49 |
binding residues | 49 |
infected individuals | 49 |
control mice | 49 |
cell cultures | 49 |
reads per | 49 |
highly sensitive | 49 |
ucsf chimera | 49 |
hopfield networks | 49 |
genes associated | 49 |
done using | 49 |
throughput sequencing | 48 |
goat anti | 48 |
significant effect | 48 |
wash buffer | 48 |
processed using | 48 |
buffered saline | 48 |
protein complexes | 48 |
host protein | 48 |
foot placement | 48 |
see also | 48 |
allele frequency | 48 |
virus rna | 48 |
influenza data | 48 |
emerging infectious | 48 |
school health | 48 |
control group | 48 |
england biolabs | 48 |
sample collection | 48 |
mononuclear cells | 48 |
read depth | 48 |
clinical course | 48 |
stop codon | 48 |
principal component | 48 |
central nervous | 47 |
step rt | 47 |
side chains | 47 |
mice infected | 47 |
million people | 47 |
right panel | 47 |
highly variable | 47 |
gene sets | 47 |
like particles | 47 |
stress response | 47 |
life technologies | 47 |
emerging coronaviruses | 47 |
upper respiratory | 47 |
acid substitutions | 47 |
ko mice | 47 |
washed twice | 47 |
pancreatic islets | 47 |
cov ratg | 47 |
corona virus | 47 |
cystic fibrosis | 47 |
caenorhabditis elegans | 47 |
cells via | 47 |
sequencing reads | 47 |
peptide vaccine | 47 |
current pandemic | 47 |
lower respiratory | 47 |
link prediction | 47 |
neutralization assay | 47 |
endothelial cell | 47 |
coronavirus infections | 47 |
amplicon sequencing | 47 |
nucleotide sequence | 47 |
accessory proteins | 47 |
gold standard | 46 |
olfactory sensory | 46 |
motor cortex | 46 |
primary antibodies | 46 |
mhc i | 46 |
effect size | 46 |
zar orthologs | 46 |
sensory neurons | 46 |
may lead | 46 |
protein level | 46 |
also shown | 46 |
nonstructural protein | 46 |
disease control | 46 |
log fold | 46 |
healthy donors | 46 |
health services | 46 |
vesicular stomatitis | 46 |
copy numbers | 46 |
angiotensin ii | 46 |
san diego | 45 |
genome replication | 45 |
human primates | 45 |
quantified using | 45 |
human genes | 45 |
respiratory virus | 45 |
phylogenetic trees | 45 |
health emergency | 45 |
high resolution | 45 |
critically ill | 45 |
multiple sclerosis | 45 |
molecular mechanism | 45 |
protease tmprss | 45 |
ion channel | 45 |
fold increase | 45 |
nasopharyngeal swabs | 45 |
specific cell | 45 |
cov orf | 45 |
cancer cell | 45 |
recently reported | 45 |
aged mice | 45 |
protein levels | 45 |
health care | 45 |
magnetic beads | 45 |
fluorescence intensity | 45 |
malayan pangolins | 45 |
respiratory failure | 45 |
blood mononuclear | 45 |
small number | 45 |
negative controls | 45 |
low viral | 45 |
infected animals | 45 |
zikv infection | 44 |
virus neutralization | 44 |
viral sequences | 44 |
salt bridges | 44 |
mouse models | 44 |
tmprss cells | 44 |
target protein | 44 |
sino biological | 44 |
sybr green | 44 |
immune receptor | 44 |
peptide pools | 44 |
light chain | 44 |
serially diluted | 44 |
terminal region | 44 |
enhanced rnai | 44 |
severe respiratory | 44 |
membrane proteins | 44 |
cell fusion | 44 |
highly similar | 43 |
genomic data | 43 |
therapeutic targets | 43 |
also tested | 43 |
drug target | 43 |
cell receptors | 43 |
treg cells | 43 |
protein folding | 43 |
interferon response | 43 |
african green | 43 |
binding energy | 43 |
broadly neutralizing | 43 |
test whether | 43 |
inflammatory cytokine | 43 |
different countries | 43 |
expression profiling | 43 |
clonal variants | 43 |
severe patients | 43 |
host receptor | 43 |
nlrp inflammasome | 43 |
molecular basis | 43 |
proximal origin | 43 |
across multiple | 43 |
stomatitis virus | 43 |
herpes simplex | 43 |
electron density | 43 |
free energies | 43 |
coronavirus genome | 43 |
bronchoalveolar lavage | 43 |
randomly selected | 43 |
primary site | 43 |
new york | 43 |
novel human | 42 |
chadox ncov | 42 |
primer set | 42 |
neutralize sars | 42 |
transmission dynamics | 42 |
identified using | 42 |
viral copies | 42 |
natural language | 42 |
inhibitory effect | 42 |
interaction map | 42 |
orf proteins | 42 |
swab samples | 42 |
species transmission | 42 |
structural biology | 42 |
blood cells | 42 |
three independent | 42 |
cellular entry | 42 |
adaptive immunity | 42 |
bd biosciences | 42 |
standard deviations | 42 |
supplementary information | 42 |
previously identified | 42 |
potential role | 42 |
affinity maturation | 42 |
linear regression | 42 |
ifn signaling | 42 |
similar results | 42 |
nonsynonymous mutations | 42 |
open source | 42 |
cov rbd | 42 |
angiotensin system | 42 |
downstream analysis | 41 |
viral shedding | 41 |
igg liposomes | 41 |
domestic cats | 41 |
genes proteins | 41 |
structural protein | 41 |
oxidative stress | 41 |
gap junctions | 41 |
muscle cells | 41 |
cell clusters | 41 |
express ace | 41 |
induced lung | 41 |
low frequency | 41 |
point mutations | 41 |
cm long | 41 |
current covid | 41 |
healthy controls | 41 |
potential drug | 41 |
transmembrane protein | 41 |
conserved residues | 41 |
mm edta | 41 |
secretory cells | 41 |
essential role | 41 |
evolutionary history | 41 |
host genomic | 41 |
lymph nodes | 41 |
mechanical ventilation | 41 |
fastq files | 41 |
case study | 41 |
gisaid database | 41 |
false discovery | 41 |
discovery rate | 41 |
electrostatic interactions | 41 |
high degree | 41 |
cell sequencing | 41 |
convolutional neural | 41 |
ace mrna | 41 |
antiviral effects | 41 |
antigen presentation | 41 |
viral receptor | 41 |
natural selection | 41 |
life history | 41 |
different concentrations | 41 |
iav infection | 41 |
coronavirus nsp | 41 |
expression pattern | 41 |
using different | 41 |
inflammatory bowel | 40 |
epitope prediction | 40 |
human serum | 40 |
primer probe | 40 |
population size | 40 |
expression system | 40 |
image analysis | 40 |
expression vector | 40 |
cells within | 40 |
detected using | 40 |
copies per | 40 |
may affect | 40 |
humoral immune | 40 |
human neutralizing | 40 |
lung inflammation | 40 |
higher affinity | 40 |
salt bridge | 40 |
new insights | 40 |
saccharomyces cerevisiae | 40 |
human brain | 40 |
nonstructural proteins | 40 |
insulin secretion | 40 |
novel sars | 40 |
logistic regression | 40 |
exclusion chromatography | 40 |
beat gesture | 40 |
also performed | 40 |
hela cells | 40 |
membrane vesicles | 40 |
supplementary data | 40 |
high sensitivity | 40 |
protein trimer | 40 |
genetic variants | 40 |
sexual selection | 40 |
related viruses | 40 |
small intestine | 40 |
domain complexed | 40 |
two separate | 40 |
receptor usage | 40 |
nasopharyngeal swab | 40 |
human pluripotent | 40 |
antiviral responses | 40 |
purifying selection | 40 |
deep sequencing | 40 |
viral pathogenesis | 40 |
mm mgcl | 40 |
mortality rate | 39 |
kidney injury | 39 |
spike glycoproteins | 39 |
rna isolation | 39 |
drug resistance | 39 |
statistical analyses | 39 |
blood flow | 39 |
systems biology | 39 |
tissue distribution | 39 |
three viruses | 39 |
dn ds | 39 |
tree shrew | 39 |
structural features | 39 |
molecular simulations | 39 |
interferon signaling | 39 |
clinical outcomes | 39 |
two types | 39 |
cells well | 39 |
learning methods | 39 |
control samples | 39 |
national institutes | 39 |
cov replication | 39 |
tcr signaling | 39 |
remains unclear | 39 |
fusion proteins | 39 |
analysis tools | 39 |
mechanisms underlying | 39 |
increases infectivity | 39 |
high specificity | 39 |
broad spectrum | 39 |
based drug | 39 |
sense rna | 39 |
healthy individuals | 39 |
false positives | 39 |
well known | 39 |
exact test | 39 |
fusion conformation | 39 |
tree shrews | 39 |
broad range | 39 |
significantly enriched | 38 |
raw sequencing | 38 |
serum albumin | 38 |
evoked potentials | 38 |
immunosequencing data | 38 |
distance matrix | 38 |
fda approved | 38 |
text mining | 38 |
may explain | 38 |
domain antibodies | 38 |
two proteins | 38 |
supplementary tables | 38 |
medium containing | 38 |
clinical studies | 38 |
based analysis | 38 |
standard curve | 38 |
outer membrane | 38 |
control cells | 38 |
coronavirus nucleocapsid | 38 |
study also | 38 |
bronchial epithelial | 38 |
virus detection | 38 |
glycan shield | 38 |
severe pneumonia | 38 |
climate change | 38 |
breast cancer | 38 |
primer sequences | 38 |
version posted | 38 |
host interaction | 38 |
coronavirus rna | 38 |
tissue samples | 38 |
many different | 38 |
also show | 38 |
crucial role | 38 |
data demonstrate | 38 |
positive controls | 38 |
dp mice | 38 |
consensus sequence | 38 |
immune status | 38 |
ace structure | 38 |
public clones | 38 |
animal care | 38 |
tissue sections | 38 |
calculated based | 38 |
host range | 38 |
electron microscope | 37 |
simplex virus | 37 |
grid search | 37 |
sequences using | 37 |
starting point | 37 |
extracellular matrix | 37 |
nsp proteins | 37 |
host defense | 37 |
conserved across | 37 |
lower levels | 37 |
molecular clock | 37 |
thermo scientific | 37 |
sequence homology | 37 |
convalescent subjects | 37 |
training set | 37 |
first two | 37 |
therapeutic options | 37 |
reverse genetics | 37 |
protein secondary | 37 |
mep amplitude | 37 |
naturally occurring | 37 |
gene regulatory | 37 |
lung pathology | 37 |
surface glycoprotein | 37 |
assay using | 37 |
conformational dynamics | 37 |
hong kong | 37 |
necrosis factor | 37 |
false negatives | 37 |
host antiviral | 37 |
domestic animals | 37 |
functional characterization | 37 |
rna expression | 37 |
respiratory system | 37 |
phylogenetic analyses | 37 |
systematic reviews | 37 |
national center | 37 |
heparan sulfate | 37 |
expression profile | 37 |
one sample | 37 |
constructed using | 37 |
heptad repeat | 37 |
neutralization activity | 37 |
functional basis | 37 |
airway epithelia | 36 |
normal mode | 36 |
post hoc | 36 |
transmission electron | 36 |
immune activation | 36 |
viral evolution | 36 |
virus evolution | 36 |
coronavirus entry | 36 |
solvent accessibility | 36 |
genes encoding | 36 |
learning models | 36 |
human lungs | 36 |
bowel disease | 36 |
gene assay | 36 |
antiviral immune | 36 |
control animals | 36 |
rna structure | 36 |
inflamed lungs | 36 |
side effects | 36 |
whitney test | 36 |
cultured cells | 36 |
viral transmission | 36 |
highly specific | 36 |
cell identity | 36 |
using graphpad | 36 |
national institute | 36 |
therapeutic potential | 36 |
studies using | 36 |
asked whether | 36 |
comparisons test | 36 |
hla class | 36 |
stromal cells | 36 |
infected pneumonia | 36 |
computing platform | 36 |
canonical autophagy | 36 |
em maps | 36 |
spreader nodes | 36 |
time course | 36 |
heart failure | 36 |
outgroup aversion | 36 |
may serve | 36 |
hek cells | 36 |
recently emerged | 36 |
human receptor | 36 |
cell signaling | 36 |
domestic cat | 36 |
viral genes | 36 |
cells treated | 36 |
coding regions | 36 |
cell lysates | 36 |
implanted signals | 36 |
subunit vaccine | 36 |
virus particle | 36 |
escape mutants | 36 |
immune signaling | 35 |
green monkey | 35 |
pattern recognition | 35 |
avian influenza | 35 |
viral fusion | 35 |
transport medium | 35 |
alertness level | 35 |
visual cortex | 35 |
free water | 35 |
cell analysis | 35 |
rbd proteins | 35 |
viral membrane | 35 |
mushroom body | 35 |
protein function | 35 |
donut pcr | 35 |
pathway enrichment | 35 |
two days | 35 |
limited number | 35 |
injured lungs | 35 |
bioconductor package | 35 |
one week | 35 |
negatively charged | 35 |
virus genomes | 35 |
vast majority | 35 |
two weeks | 35 |
age groups | 35 |
positively charged | 35 |
internal control | 35 |
poorly understood | 35 |
direct contact | 35 |
hpiv pref | 35 |
tumor necrosis | 35 |
disease caused | 35 |
genomic regions | 35 |
network inference | 35 |
washed three | 35 |
left panel | 35 |
software package | 35 |
therapeutic strategies | 35 |
der waals | 35 |
verso step | 35 |
pv ihucovid | 35 |
viral quasispecies | 35 |
immune receptors | 35 |
highly potent | 35 |
transport media | 35 |
mediated isothermal | 35 |
ace isoforms | 35 |
antiviral agents | 35 |
analysis reveals | 35 |
different species | 35 |
nucleotide polymorphisms | 35 |
smoking status | 35 |
findings indicate | 35 |
specific igg | 35 |
consensus sequences | 35 |
liquid nitrogen | 35 |
predicted using | 35 |
informed consent | 34 |
higher expression | 34 |
negative samples | 34 |
ncbi database | 34 |
early stage | 34 |
culture supernatant | 34 |
may represent | 34 |
hcl ph | 34 |
data science | 34 |
reactive oxygen | 34 |
potential vaccine | 34 |
genetic data | 34 |
taq dna | 34 |
human populations | 34 |
diminazene aceturate | 34 |
rna sequences | 34 |
two mutations | 34 |
viral life | 34 |
representation learning | 34 |
aligned using | 34 |
positive results | 34 |
language processing | 34 |
gel electrophoresis | 34 |
spike ectodomain | 34 |
protein family | 34 |
study provides | 34 |
viral strains | 34 |
statistical computing | 34 |
ray crystal | 34 |
vehicle control | 34 |
spike trimer | 34 |
cell suspensions | 34 |
close proximity | 34 |
size exclusion | 34 |
model building | 34 |
cardiovascular disease | 34 |
cmv dataset | 34 |
raw reads | 34 |
ribosomal frameshifting | 34 |
paneth cells | 34 |
approved drug | 34 |
rna levels | 34 |
new species | 34 |
principal components | 34 |
person transmission | 34 |
interaction networks | 34 |
ii iii | 34 |
supplementary methods | 34 |
muc ac | 34 |
saliva samples | 34 |
clinical data | 34 |
virus strains | 34 |
pseudotyped virus | 34 |
autoimmune diseases | 34 |
signal transduction | 34 |
map reveals | 34 |
ill patients | 33 |
lung tissues | 33 |
reads mapping | 33 |
second syllable | 33 |
intestinal epithelial | 33 |
cohesin genes | 33 |
throughput screening | 33 |
less likely | 33 |
mean square | 33 |
will help | 33 |
translation initiation | 33 |
tested whether | 33 |
infrequent events | 33 |
beta cells | 33 |
lateral protocerebrum | 33 |
derived cms | 33 |
human antibody | 33 |
opioid receptors | 33 |
genome copy | 33 |
serological assays | 33 |
tcid ml | 33 |
acid detection | 33 |
signalling pathway | 33 |
first syllable | 33 |
false negative | 33 |
among different | 33 |
drug administration | 33 |
coding sequence | 33 |
live virus | 33 |
cynomolgus macaques | 33 |
confidence interval | 33 |
prefusion state | 33 |
seq datasets | 33 |
molar ratio | 33 |
autistic traits | 33 |
inhibit viral | 33 |
hla alleles | 33 |
rhesus macaque | 33 |
intermediate hosts | 33 |
increased risk | 33 |
convalescent patients | 33 |
pdb entry | 33 |
correlation coefficient | 33 |
treated mice | 33 |
rabies virus | 33 |
proteins involved | 33 |
nasal cavity | 33 |
thank dr | 33 |
cell membranes | 33 |
brain injury | 33 |
data integration | 33 |
human intestinal | 33 |
functional analysis | 33 |
cancer patients | 33 |
membrane binding | 33 |
sequence conservation | 33 |
imaging system | 33 |
gene regulation | 33 |
alveolar cells | 33 |
pandemic caused | 33 |
viral rnas | 33 |
human adult | 33 |
main effect | 33 |
current sars | 33 |
recently published | 33 |
average number | 33 |
zebrafish larvae | 33 |
pathogenic coronaviruses | 33 |
protein solubility | 33 |
organ failure | 33 |
long structural | 33 |
opioid receptor | 32 |
based approaches | 32 |
investigate whether | 32 |
rapid detection | 32 |
pcr reaction | 32 |
female mice | 32 |
risk factor | 32 |
protein receptor | 32 |
antiviral defense | 32 |
root mean | 32 |
virus receptor | 32 |
pcr assay | 32 |
input object | 32 |
ace genes | 32 |
like receptors | 32 |
skeletal muscle | 32 |
iii ifn | 32 |
scientific community | 32 |
common ancestor | 32 |
drug repositioning | 32 |
alertness levels | 32 |
entry receptor | 32 |
dna vaccine | 32 |
worth noting | 32 |
purified using | 32 |
early stages | 32 |
dendritic cell | 32 |
infected cell | 32 |
tailed amplicon | 32 |
enabled us | 32 |
cell fate | 32 |
viral pneumonia | 32 |
beat gestures | 32 |
genomic characterization | 32 |
host innate | 32 |
delta opioid | 32 |
mm long | 32 |
first case | 32 |
will also | 32 |
conformational change | 32 |
local resolution | 32 |
antibodies targeting | 32 |
enzymatic activity | 32 |
confocal microscope | 32 |
catalytic activity | 32 |
binding pockets | 32 |
based attention | 32 |
high performance | 32 |
assess whether | 32 |
oxygen species | 32 |
polymorphism ratios | 32 |
generation times | 32 |
global spread | 32 |
genetic code | 32 |
rna interactions | 32 |
relatively small | 32 |
clonal expansion | 32 |
human disease | 32 |
treg cell | 32 |
cdc sars | 32 |
virus titer | 32 |
primary antibody | 32 |
wide association | 32 |
incubation period | 32 |
seven days | 32 |
human samples | 32 |
selection pressure | 32 |
may reflect | 32 |
read alignment | 32 |
biosafety level | 32 |
many viruses | 32 |
length sars | 32 |
cdna synthesis | 32 |
complex structure | 32 |
situation report | 32 |
wide variety | 32 |
natural infection | 32 |
alveolar type | 32 |
therapeutic target | 31 |
target dna | 31 |
visualization system | 31 |
scale bar | 31 |
tcrb repertoire | 31 |
tandem mass | 31 |
spike antigen | 31 |
signalling pathways | 31 |
hace receptor | 31 |
fusion state | 31 |
dynamic range | 31 |
spectral density | 31 |
transgenic lines | 31 |
pro cov | 31 |
detection limit | 31 |
co emissions | 31 |
hot spots | 31 |
urgently needed | 31 |
trade liberalization | 31 |
case fatality | 31 |
sample sizes | 31 |
agarose gel | 31 |
based design | 31 |
potent antiviral | 31 |
tested positive | 31 |
identify potential | 31 |
host interactions | 31 |
genomic epidemiology | 31 |
stimulated gene | 31 |
prefusion spike | 31 |
image processing | 31 |
lipid bilayer | 31 |
four different | 31 |
i interferons | 31 |
specific memory | 31 |
poly i | 31 |
enveloped virus | 31 |
dna sequencing | 31 |
based method | 31 |
previous findings | 31 |
immune repertoires | 31 |
three major | 31 |
dna sequence | 31 |
data also | 31 |
low ph | 31 |
clinical specimens | 31 |
therapeutic development | 31 |
protein rbd | 31 |
wilcoxon rank | 31 |
western blotting | 31 |
taxonomic classification | 31 |
data presented | 31 |
brain endothelial | 31 |
red blood | 31 |
may cause | 31 |
increasing concentrations | 31 |
plasmodium falciparum | 31 |
scale bars | 31 |
per million | 31 |
golden syrian | 31 |
host gene | 31 |
also examined | 31 |
molecule inhibitors | 31 |
mean value | 31 |
located within | 31 |
detect sars | 31 |
nk cells | 31 |
length spike | 31 |
dependent enhancement | 31 |
replication cycle | 31 |
low quality | 31 |
severe cases | 31 |
frequency domain | 31 |
basal cell | 31 |
coronavirus pneumonia | 31 |
like coronavirus | 31 |
acid changes | 31 |
transcriptional regulation | 31 |
coronavirus receptor | 30 |
north america | 30 |
mutually exclusive | 30 |
ct value | 30 |
plaque assays | 30 |
structural information | 30 |
germinal center | 30 |
mitotic centrosome | 30 |
also assessed | 30 |
million confirmed | 30 |
plasma cells | 30 |
life sciences | 30 |
hubei province | 30 |
viral titer | 30 |
computational methods | 30 |
hepes ph | 30 |
disulfide bonds | 30 |
positively selected | 30 |
transcriptomic data | 30 |
cell expression | 30 |
virus hemagglutinin | 30 |
sanger sequencing | 30 |
virus spread | 30 |
analysis shows | 30 |
fever virus | 30 |
normal human | 30 |
infected samples | 30 |
inflammasome activation | 30 |
heat map | 30 |
ribosomal rna | 30 |
world data | 30 |
seq reads | 30 |
nuclear export | 30 |
large numbers | 30 |
hyperparameter search | 30 |
whole brain | 30 |
live sars | 30 |
assay kit | 30 |
actin cytoskeleton | 30 |
results provide | 30 |
supporting information | 30 |
evaluated using | 30 |
different time | 30 |
convalescent individuals | 30 |
abundance estimation | 30 |
cell subtypes | 30 |
molecular modeling | 30 |
target proteins | 30 |
reference genomes | 30 |
two hours | 30 |
cytokine release | 30 |
anammox bacteria | 30 |
ec values | 30 |
mouse brain | 30 |
novel method | 30 |
human antibodies | 30 |
gene lists | 30 |
atomic model | 30 |
next sought | 30 |
robotic system | 30 |
viral transport | 30 |
untranslated region | 30 |
may help | 30 |
outer limbus | 30 |
ace orthologs | 30 |
default settings | 30 |
also possible | 30 |
nasal epithelial | 30 |
spread across | 30 |
adverse effects | 30 |
mm imidazole | 30 |
acquired using | 30 |
ub organoid | 30 |
magnetic resonance | 30 |
coronaviridae family | 30 |
pathogen detection | 30 |
linked immunosorbent | 30 |
pulmonary fibrosis | 30 |
different viral | 30 |
economic growth | 30 |
synaptic scaling | 30 |
sequencing depth | 30 |
igg fc | 30 |
cell transcriptomic | 30 |
tissue damage | 30 |
lavage fluid | 30 |
one day | 30 |
rank test | 30 |
polymerase complex | 29 |
binding assay | 29 |
formic acid | 29 |
wt mice | 29 |
modified cdc | 29 |
drives development | 29 |
species severe | 29 |
containing mm | 29 |
vascular endothelial | 29 |
central role | 29 |
surface expression | 29 |
cells express | 29 |
stimulated genes | 29 |
nsp complex | 29 |
red line | 29 |
rapid development | 29 |
sequence embedding | 29 |
accession id | 29 |
least three | 29 |
studies will | 29 |
noise ratio | 29 |
incubated overnight | 29 |
viruses including | 29 |
respiratory viral | 29 |
retrospective cohort | 29 |
data show | 29 |
nile virus | 29 |
syrian hamsters | 29 |
per day | 29 |
infected vero | 29 |
viral gene | 29 |
host genes | 29 |
sequence motifs | 29 |
rheumatoid arthritis | 29 |
cortical representation | 29 |
brain barrier | 29 |
long term | 29 |
per group | 29 |
protein nsp | 29 |
conformational states | 29 |
inhibitors targeting | 29 |
coronavirus papain | 29 |
glucose homeostasis | 29 |
lung cell | 29 |
surface protein | 29 |
next day | 29 |
potent inhibitor | 29 |
bl mice | 29 |
virus transmission | 29 |
convalescent sera | 29 |
samples using | 29 |
infection model | 29 |
insect cells | 29 |
polyclonal antibody | 29 |
acid identity | 29 |
alexa fluor | 29 |
highly efficient | 29 |
cysteine residues | 29 |
wilcoxon signed | 29 |
biotechnology information | 29 |
positive sense | 29 |
specific expression | 29 |
driven entry | 29 |
prepared using | 29 |
diabetes mellitus | 29 |
cell gene | 29 |
sfv proteins | 29 |
gap junction | 29 |
interactive web | 29 |
drug binding | 29 |
human health | 29 |
mouse igg | 29 |
human bronchial | 29 |
recently described | 29 |
treated group | 29 |
data suggests | 29 |
west nile | 29 |
shed light | 29 |
excess proton | 29 |
cells exposed | 29 |
lung disease | 29 |
biologically relevant | 29 |
existing drugs | 29 |
transfected cells | 29 |
subcellular localization | 29 |
santa fe | 29 |
results also | 29 |
protease cleavage | 29 |
cytopathic effects | 28 |
mhc ii | 28 |
cpg force | 28 |
igg mbcs | 28 |
imbalanced host | 28 |
response curves | 28 |
research articles | 28 |
model system | 28 |
conserved among | 28 |
conducted using | 28 |
viral growth | 28 |
goblet cells | 28 |
may act | 28 |
visual molecular | 28 |
examined whether | 28 |
network representation | 28 |
surface plasmon | 28 |
lesser extent | 28 |
mitochondrial dysfunction | 28 |
preliminary report | 28 |
igg antibody | 28 |
regulated genes | 28 |
pearson correlation | 28 |
start codons | 28 |
latent space | 28 |
blocking buffer | 28 |
cold pbs | 28 |
variable genes | 28 |
molecular patterns | 28 |
input sequences | 28 |
coronavirus outbreak | 28 |
biological functions | 28 |
dipeptidyl peptidase | 28 |
led us | 28 |
respiratory infections | 28 |
web portal | 28 |
viral pathogens | 28 |
resident memory | 28 |
brain regions | 28 |
tcr repertoire | 28 |
biological samples | 28 |
higher viral | 28 |
infectious cdna | 28 |
cell memory | 28 |
antiviral activities | 28 |
higher binding | 28 |
intensive care | 28 |
using either | 28 |
cells ml | 28 |
plasmon resonance | 28 |
cellular immunity | 28 |
antibody production | 28 |
reads mapped | 28 |
adj cpg | 28 |
brain tissue | 28 |
tms pulse | 28 |
protein stability | 28 |
duplex sequencing | 28 |
protein production | 28 |
showed high | 28 |
using anti | 28 |
significant decrease | 28 |
protein domain | 28 |
cell transcriptomics | 28 |
human saliva | 28 |
interaction network | 28 |
high concentration | 28 |
representative images | 28 |
statistical tests | 28 |
staphylococcus aureus | 28 |
dose group | 28 |
findings provide | 28 |
cell suspension | 28 |
cl pro | 28 |
also included | 28 |
possibly due | 28 |
cellular immune | 28 |
codon bias | 28 |
mice showed | 28 |
go terms | 28 |
fusion core | 28 |
closed state | 28 |
analysis identified | 28 |
binding regions | 27 |
controlled trial | 27 |
viral particle | 27 |
data point | 27 |
bound state | 27 |
also revealed | 27 |
associated molecular | 27 |
highly enriched | 27 |
much less | 27 |
descriptive study | 27 |
disease ecology | 27 |
plant species | 27 |
another study | 27 |
entry factors | 27 |
remains unknown | 27 |
genbank accession | 27 |
like coronaviruses | 27 |
first reported | 27 |
proinflammatory cytokines | 27 |
hpv pmd | 27 |
threshold value | 27 |
thermal cycler | 27 |
bioinformatics analysis | 27 |
main orf | 27 |
future work | 27 |
dynamics simulation | 27 |
pathogenic coronavirus | 27 |
sum test | 27 |
social distancing | 27 |
changes induced | 27 |
peptide sequences | 27 |
physiological conditions | 27 |
results support | 27 |
treated animals | 27 |
rna molecules | 27 |
motor inhibition | 27 |
population coverage | 27 |
lung organoids | 27 |
wpb size | 27 |
structural data | 27 |
close contact | 27 |
mice immunized | 27 |
showed higher | 27 |
genome size | 27 |
pneumonia associated | 27 |
extraction step | 27 |
positive patients | 27 |
ctl epitopes | 27 |
unexposed subjects | 27 |
samples collected | 27 |
learning rate | 27 |
structural modeling | 27 |
small animal | 27 |
global public | 27 |
will allow | 27 |
therapeutic interventions | 27 |
also reported | 27 |
four times | 27 |
antiviral therapy | 27 |
virus survival | 27 |
pangolin origin | 27 |
high accuracy | 27 |
different human | 27 |
provide evidence | 27 |
submucosal gland | 27 |
studies suggest | 27 |
genomic sequence | 27 |
transgene silencing | 27 |
adenovirus type | 27 |
old mice | 27 |
viral activity | 27 |
viral attachment | 27 |
data available | 27 |
participants completed | 27 |
vice versa | 27 |
user interface | 27 |
monte carlo | 27 |
ongoing covid | 27 |
oxford nanopore | 27 |
lipid metabolism | 27 |
preprint servers | 27 |
ab initio | 27 |
pcr system | 27 |
fluorescence signal | 27 |
disulfide bond | 27 |
recombinant human | 27 |
significant changes | 27 |
viral clearance | 27 |
probe sets | 27 |
attention effect | 27 |
rna editing | 27 |
multiple testing | 27 |
different tissues | 26 |
silicon nitride | 26 |
protein response | 26 |
mini kit | 26 |
culture media | 26 |
interaction partners | 26 |
veroe cells | 26 |
enrichment score | 26 |
potent inhibitors | 26 |
contact tracing | 26 |
mm na | 26 |
different organs | 26 |
reveals targets | 26 |
clinical signs | 26 |
cell survival | 26 |
regulatory elements | 26 |
success rate | 26 |
lymph node | 26 |
start codon | 26 |
gene segments | 26 |
memory cells | 26 |
high risk | 26 |
future research | 26 |
conservation score | 26 |
convergent evolution | 26 |
familial cluster | 26 |
closed conformation | 26 |
fluorescence microscopy | 26 |
stranded dna | 26 |
mm sodium | 26 |
acid residue | 26 |
mm dtt | 26 |
ang ii | 26 |
pcr product | 26 |
cov genome | 26 |
significantly decreased | 26 |
slightly higher | 26 |
glycosylation sites | 26 |
enr cd | 26 |
emerging viruses | 26 |
crystal violet | 26 |
many studies | 26 |
viral diseases | 26 |
pathogenic viruses | 26 |
neutralization test | 26 |
unexposed individuals | 26 |
differences among | 26 |
two sets | 26 |
molecular graphics | 26 |
membrane glycoprotein | 26 |
clinical symptoms | 26 |
high coverage | 26 |
interferon production | 26 |
novel therapeutic | 26 |
limb muscles | 26 |
update rule | 26 |
anp low | 26 |
three qrt | 26 |
protease activity | 26 |
may result | 26 |
current status | 26 |
dna conjugates | 26 |
overlapping genes | 26 |
glucose tolerance | 26 |
family cluster | 26 |
envelope glycoprotein | 26 |
therapeutic strategy | 26 |
severe symptoms | 26 |
antibodies elicited | 26 |
take place | 26 |
stem ii | 26 |
subunit vaccines | 26 |
meta path | 26 |
huh cells | 26 |
human fetal | 26 |
igg titers | 26 |
recurrent neural | 26 |
coronavirus nonstructural | 26 |
pcr testing | 26 |
viral population | 26 |
exploratory research | 26 |
across participants | 26 |
treat covid | 26 |
mesh ewald | 26 |
confocal microscopy | 26 |
power spectrum | 26 |
streptococcus pyogenes | 26 |
barr virus | 26 |
prism software | 26 |
pangolin cov | 26 |
potential target | 26 |
human primate | 26 |
learning approaches | 26 |
unfolded protein | 26 |
recombinant proteins | 26 |
murine coronavirus | 26 |
correlation analysis | 26 |
using rna | 26 |
molecular evolution | 26 |
blood cell | 26 |
hub proteins | 26 |
trim proteins | 26 |
using standard | 26 |
accession numbers | 26 |
plasmacytoid dendritic | 26 |
comprehensive analysis | 26 |
ace proteins | 26 |
computed using | 26 |
inner limbus | 26 |
homologous recombination | 26 |
radiology reports | 26 |
speech perception | 26 |
cellular membranes | 26 |
transcriptional response | 26 |
immunized mice | 26 |
intrinsically disordered | 26 |
mental health | 26 |
encephalitis virus | 26 |
steady state | 26 |
high similarity | 26 |
experimental conditions | 26 |
also demonstrated | 26 |
assortative mating | 26 |
pitch discrimination | 26 |
extracted using | 26 |
base pair | 26 |
end reads | 26 |
nonhuman primate | 26 |
major role | 26 |
artificial intelligence | 26 |
spike mutation | 26 |
mortality rates | 26 |
based sequence | 26 |
rna sequence | 26 |
two viruses | 25 |
physiological ph | 25 |
vaccinia virus | 25 |
interleaved harmonic | 25 |
predictive performance | 25 |
igg ab | 25 |
missense mutations | 25 |
showed similar | 25 |
nonhuman primates | 25 |
ongoing pandemic | 25 |
cellular receptor | 25 |
lateral ankle | 25 |
virus binding | 25 |
myeloid cells | 25 |
pyrimidine biosynthesis | 25 |
recent years | 25 |
intestinal organoids | 25 |
significant reduction | 25 |
marginated neutrophils | 25 |
increasing number | 25 |
plate reader | 25 |
ace receptors | 25 |
host interactome | 25 |
experimental results | 25 |
drug concentrations | 25 |
homo sapiens | 25 |
conserved regions | 25 |
initial model | 25 |
interferon responses | 25 |
effective vaccine | 25 |
study sars | 25 |
based peptide | 25 |
potent neutralization | 25 |
studies showed | 25 |
main text | 25 |
mass spectrometer | 25 |
study design | 25 |
silico analysis | 25 |
transmembrane serine | 25 |
disease risk | 25 |
confidence intervals | 25 |
term memory | 25 |
authentic sars | 25 |
human immune | 25 |
infectious dose | 25 |
lamp assay | 25 |
bat coronaviruses | 25 |
functional assessment | 25 |
visual inspection | 25 |
provide important | 25 |
cholesterol transport | 25 |
virus strain | 25 |
different levels | 25 |
times higher | 25 |
open conformation | 25 |
plasmid dna | 25 |
airway cells | 25 |
middle eastern | 25 |
receptor signaling | 25 |
analysed using | 25 |
data categories | 25 |
quantitative pcr | 25 |
distantly related | 25 |
signal intensity | 25 |
wavelet based | 25 |
low expression | 25 |
serum igg | 25 |
identified two | 25 |
cellular processes | 25 |
understanding sars | 25 |
software version | 25 |
time step | 25 |
infect humans | 25 |
associated protein | 25 |
quantitative analysis | 25 |
physicochemical properties | 25 |
respiratory epithelium | 25 |
mutational signatures | 25 |
also present | 25 |
chemical mapping | 25 |
limbal epithelial | 25 |
clonal genotype | 25 |
effectively inhibit | 25 |
clinically relevant | 25 |
site residues | 25 |
data generated | 25 |
binding modes | 25 |
infectious sars | 25 |
indicated time | 25 |
spike peptide | 25 |
electron acceptor | 25 |
institutional review | 25 |
aa sequences | 25 |
cell transcriptome | 25 |
sars plpro | 25 |
indicating person | 25 |
cov infections | 25 |
gc content | 25 |
statistical power | 25 |
human sera | 25 |
also significantly | 25 |
tidal volume | 25 |
cell number | 25 |
assays using | 25 |
created using | 25 |
coronavirus orf | 25 |
viral spread | 25 |
illumina sequencing | 25 |
cell division | 25 |
following infection | 25 |
extremely high | 25 |
fold serial | 25 |
cov genomes | 25 |
human adenovirus | 25 |
inhibits sars | 25 |
rapid spread | 25 |
autism spectrum | 25 |
intermediate host | 25 |
antiviral immunity | 25 |
clinical severity | 25 |
pixel size | 25 |
treatment group | 25 |
sequence alignments | 25 |
rna structures | 25 |
cells showed | 25 |
high number | 25 |
investigated whether | 25 |
envelope proteins | 25 |
beta cell | 25 |
web application | 25 |
pcr using | 25 |
unique molecular | 25 |
hydrogen bonding | 25 |
coronavirus indicating | 25 |
two additional | 24 |
methods section | 24 |
different populations | 24 |
well established | 24 |
also suggests | 24 |
marker gene | 24 |
cell function | 24 |
di erent | 24 |
key residues | 24 |
clinically approved | 24 |
water bath | 24 |
em data | 24 |
unless otherwise | 24 |
disease transmission | 24 |
adult pancreas | 24 |
dna rna | 24 |
fluorescent signal | 24 |
nm spint | 24 |
genome composition | 24 |
high binding | 24 |
existing immunity | 24 |
healthy control | 24 |
multiple cell | 24 |
rbd region | 24 |
rna samples | 24 |
genetic analysis | 24 |
decision tree | 24 |
based detection | 24 |
south america | 24 |
acid binding | 24 |
time spent | 24 |
data showed | 24 |
sequencing errors | 24 |
natural products | 24 |
across species | 24 |
one rbd | 24 |
might also | 24 |
coronavirus pandemic | 24 |
among others | 24 |
novel severe | 24 |
cell adhesion | 24 |
per year | 24 |
detailed analysis | 24 |
mutant frequency | 24 |
rationally designed | 24 |
kidney disease | 24 |
also confirmed | 24 |
dna damage | 24 |
cell interactions | 24 |
horseshoe bats | 24 |
major cell | 24 |
differentially regulated | 24 |
clustal omega | 24 |
virological assessment | 24 |
virus data | 24 |
analysis pipeline | 24 |
recent reports | 24 |
tissues using | 24 |
von willebrand | 24 |
homology modelling | 24 |
dna binding | 24 |
nested pcr | 24 |
emergency use | 24 |
specific viral | 24 |
coronavirus nl | 24 |
cell sorting | 24 |
homeostatic mechanisms | 24 |
also suggest | 24 |
evolutionary analysis | 24 |
also provide | 24 |
single stranded | 24 |
acute kidney | 24 |
molecular interactions | 24 |
respiratory illness | 24 |
identifying sars | 24 |
clinical use | 24 |
models using | 24 |
one another | 24 |
treatment groups | 24 |
coronavirus genomes | 24 |
green fluorescent | 24 |
vaccine targets | 24 |
phosphate buffered | 24 |
candidate genes | 24 |
time period | 24 |
complex tones | 24 |
results presented | 24 |
dnase i | 24 |
kindly provided | 24 |
surface proteins | 24 |
infectious agents | 24 |
ml penicillin | 24 |
recent advances | 24 |
tattoo ink | 24 |
viral nucleic | 24 |
freely available | 24 |
control wells | 24 |
human plasma | 24 |
receptor sequences | 24 |
experiments using | 24 |
free fatty | 24 |
tracking changes | 24 |
transcriptional changes | 24 |
cells may | 24 |
protein binds | 24 |
respiratory symptoms | 24 |
quadruplex structures | 24 |
feature selection | 24 |
used two | 24 |
disease pathogenesis | 24 |
motor evoked | 24 |
significant correlation | 24 |
solubility prediction | 24 |
analysis software | 24 |
viral control | 24 |
industrial development | 24 |
equilibrium md | 24 |
recent report | 24 |
codon optimization | 24 |
aligned reads | 24 |
background noise | 24 |
harmonic sounds | 24 |
i hla | 24 |
performed according | 24 |
cd cells | 24 |
fetal brain | 24 |
hidden markov | 24 |
chest ct | 24 |
dotted line | 24 |
recombination event | 23 |
airway epcs | 23 |
protein atlas | 23 |
massively parallel | 23 |
experimental studies | 23 |
ms analysis | 23 |
high dose | 23 |
two decades | 23 |
showed significant | 23 |
binding activity | 23 |
genomic surveillance | 23 |
mutational processes | 23 |
reference database | 23 |
harmonic tones | 23 |
healthy human | 23 |
immune cross | 23 |
pro sars | 23 |
validation set | 23 |
coding genes | 23 |
rna interactome | 23 |
observations suggest | 23 |
confirmed covid | 23 |
results suggested | 23 |
cpg content | 23 |
mediated cell | 23 |
stably transfected | 23 |
protein domains | 23 |
entry mechanisms | 23 |
expression values | 23 |
target gene | 23 |
using one | 23 |
results indicated | 23 |
hace transgenic | 23 |
different methods | 23 |
trimeric sars | 23 |
affinity chromatography | 23 |
coronavirus oc | 23 |
binding antibodies | 23 |
natural killer | 23 |
specific primers | 23 |
zikv ns | 23 |
limiting membrane | 23 |
macromolecular structure | 23 |
allow us | 23 |
slippery sequence | 23 |
nasal swabs | 23 |
flow cytometric | 23 |
feeder cells | 23 |
ethics committee | 23 |
elevated levels | 23 |
pcr master | 23 |
adult inpatients | 23 |
idseq nt | 23 |
study showed | 23 |
also shows | 23 |
ug ml | 23 |
potential targets | 23 |
see section | 23 |
lung damage | 23 |
within minutes | 23 |
reference set | 23 |
bars indicate | 23 |
coronavirus main | 23 |
viral copy | 23 |
emerging coronavirus | 23 |
old world | 23 |
also evaluated | 23 |
severe sars | 23 |
antibody repertoire | 23 |
snv calling | 23 |
blood pressure | 23 |
ribosome footprints | 23 |
deleterious mutations | 23 |
recognition receptors | 23 |
drug delivery | 23 |
humoral immunity | 23 |
open state | 23 |
random walk | 23 |
simulation time | 23 |
interaction energy | 23 |
jak stat | 23 |
time reverse | 23 |
one possible | 23 |
forming units | 23 |
cse suppression | 23 |
il ra | 23 |
dmem supplemented | 23 |
community detection | 23 |
syrian hamster | 23 |
small intestinal | 23 |
proteolytic processing | 23 |
three days | 23 |
detecting sars | 23 |
late md | 23 |
early phase | 23 |
binding kinetics | 23 |
balance mechanisms | 23 |
prediction using | 23 |
i ifns | 23 |
virus stock | 23 |
may indicate | 23 |
haddock score | 23 |
dilution series | 23 |
variant frequency | 23 |
mutational hotspots | 23 |
nhbe cells | 23 |
hydrophobic residues | 23 |
cell tropism | 23 |
conjugated anti | 23 |
single dose | 23 |
neutrophil extracellular | 23 |
chikungunya virus | 23 |
will provide | 23 |
coronavirus spikes | 23 |
inharmonic conditions | 23 |
vero cell | 23 |
ncov infection | 23 |
therapeutic efficacy | 23 |
neutralizing titers | 23 |
pulmonary edema | 23 |
per reaction | 23 |
antiviral therapies | 23 |
molecular diagnostic | 23 |
interacting residues | 23 |
rapidly spread | 23 |
sequenced using | 23 |
receptor expression | 23 |
elution buffer | 23 |
cov susceptibility | 23 |
tcr sequences | 23 |
analyses revealed | 23 |
carbon dioxide | 23 |
fold lower | 23 |
high confidence | 23 |
much larger | 23 |
nearly identical | 23 |
based assays | 23 |
stimulation intensity | 23 |
transcriptional regulator | 23 |
cell biology | 23 |
predicted epitopes | 23 |
data obtained | 23 |
interface residues | 23 |
random forest | 23 |
significance threshold | 23 |
replication machinery | 23 |